Literature DB >> 6372453

Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Interstitial and intraepithelial populations.

J B Margolick, S M Hsu, D J Volkman, K D Burman, A S Fauci.   

Abstract

The phenotypic cell surface markers of the lymphocytes present in thyroid tissue from four patients with Graves' disease were quantitatively analyzed using the avidin-biotin immunoperoxidase technique. As control specimens, normal perinodular tissues from three patients who had benign thyroid nodules resected were also studied. In contrast to normal thyroid tissue, which contained very few T cells and no B cells, thyroid tissue of all four patients with Graves' disease contained a lymphocytic infiltrate, and this could be divided into two populations of lymphocytes. The first population was located in the follicular epithelium and expressed a cytotoxic-suppressor T cell marker (Leu2a). On the average, these cells were 4.2 times as numerous in Graves' tissues as in normal tissues (p less than 0.05). Most of these cells did not express Leu1, a pan-T cell marker. The second population was found in the interstitial tissues, often within lymphoid aggregates, and 70 to 83 percent of the cells expressed Leu1. The majority of these cells expressed a helper-inducer T cell marker, Leu3a; Leu3a/Leu2a ratios within aggregates ranged from 1.9 to 2.1. The number of B cells present was small, ranging from 5.8 to 12.1 percent of the interstitial lymphocytes. These findings are consistent with the involvement of both helper-inducer and suppressor-cytotoxic T cells in a localized autoimmune reaction directed, at least in part, against the thyroid follicular epithelial cells.

Entities:  

Mesh:

Year:  1984        PMID: 6372453     DOI: 10.1016/0002-9343(84)90992-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Regulation and role of thyroid cell class II antigen expression.

Authors:  A P Weetman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S L Middleton; A Dickinson; F Clark; S J Proctor; G Proud; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Molecular heterogeneity of a Graves' thyroid-infiltrating T cell population rich in CD8+ and gamma delta+ T cells.

Authors:  P Santamaria; C Lewis; J J Barbosa
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

4.  Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.

Authors:  G F Del Prete; A Tiri; S Mariotti; A Pinchera; M Ricci; S Romagnani
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

5.  Expression of HLA ABC and DR antigens in thyroid neoplasia and correlation with mononuclear leukocyte infiltration.

Authors:  M E Fisfalen; W A Franklin; L J DeGroot; R S Cajulis; K Soltani; M Ryan; N Jones
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

6.  Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis.

Authors:  Daniel Álvarez-Sierra; Ana Marín-Sánchez; Aroa Gómez-Brey; Irene Bello; Enric Caubet; Pablo Moreno-Llorente; Anna Petit; Carles Zafón; Carmela Iglesias; Óscar González; Ricardo Pujol-Borrell
Journal:  Thyroid       Date:  2022-05-25       Impact factor: 6.506

7.  Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.

Authors:  Z Wu; E R Podack; J M McKenzie; K J Olsen; M Zakarija
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.

Authors:  N Ishikawa; K Eguchi; Y Ueki; M Nakashima; H Shimada; K Ito; S Nagataki
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.